Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Valenti

Showing results (41-50 of 438) with videos related to

Pageof 44
Sort By:
Cell Metabolism|January 9, 2020
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver DiseaseStefano Romeo, Arun Sanyal, Luca Valenti
Journal of Hepatology|May 24, 2020
Lack of genetic evidence that fatty liver disease predisposes to COVID-19Luca Valenti, Oveis Jamialahmadi, Stefano Romeo
World Journal of Gastroenterology|August 10, 2012
Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver diseaseLuca Valenti, Paola Dongiovanni, Silvia Fargion
Hepatology (Baltimore, Md.)|January 28, 2012
Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphismsLuca Valenti, Anna Alisi, Valerio Nobili
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2021
A genetic hypothesis for burnt-out steatohepatitisLuca Valenti, Stefano Romeo, Utpal Pajvani
The Journal of Biological Chemistry|March 25, 2005
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genesDavid Frescas, Luca Valenti, Domenico Accili
Journal of Hepatology|November 11, 2017
Genetics and epigenetics of NAFLD and NASH: Clinical impactMohammed Eslam, Luca Valenti, Stefano Romeo
Hepatology (Baltimore, Md.)|September 27, 2012
I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatologyLuca Valenti, Anna Alisi, Valerio Nobili
Journal of Hepatology|August 19, 2022
Reply to: "Lack of hepatic autophagy promotes severity of liver injury but not steatosis": ATG7 genetic variants behave as fatty liver disease progression modifiersGuido Baselli, Stefano Romeo, Luca Valenti
The New England Journal of Medicine|July 24, 2010
Apolipoprotein C3 gene variants in nonalcoholic fatty liver diseaseLuca Valenti, Valerio Nobili, Silvia Fargion
Pageof 44

Showing results (41-50 of 438) with videos related to

Sort By:
Pageof 44
Cell Metabolism|January 9, 2020
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver DiseaseStefano Romeo, Arun Sanyal, Luca Valenti
Journal of Hepatology|May 24, 2020
Lack of genetic evidence that fatty liver disease predisposes to COVID-19Luca Valenti, Oveis Jamialahmadi, Stefano Romeo
World Journal of Gastroenterology|August 10, 2012
Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver diseaseLuca Valenti, Paola Dongiovanni, Silvia Fargion
Hepatology (Baltimore, Md.)|January 28, 2012
Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphismsLuca Valenti, Anna Alisi, Valerio Nobili
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2021
A genetic hypothesis for burnt-out steatohepatitisLuca Valenti, Stefano Romeo, Utpal Pajvani
The Journal of Biological Chemistry|March 25, 2005
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genesDavid Frescas, Luca Valenti, Domenico Accili
Journal of Hepatology|November 11, 2017
Genetics and epigenetics of NAFLD and NASH: Clinical impactMohammed Eslam, Luca Valenti, Stefano Romeo
Hepatology (Baltimore, Md.)|September 27, 2012
I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatologyLuca Valenti, Anna Alisi, Valerio Nobili
Journal of Hepatology|August 19, 2022
Reply to: "Lack of hepatic autophagy promotes severity of liver injury but not steatosis": ATG7 genetic variants behave as fatty liver disease progression modifiersGuido Baselli, Stefano Romeo, Luca Valenti
The New England Journal of Medicine|July 24, 2010
Apolipoprotein C3 gene variants in nonalcoholic fatty liver diseaseLuca Valenti, Valerio Nobili, Silvia Fargion
Pageof 44